In Episode 29 of Stock Spotlight, host Michael dives deep into Align Technology ($ALGN), the company behind Invisalign and one of the biggest winners of the digital dentistry boom. After a massive post-pandemic re-rating, Align now trades more like a mature medtech company despite still leading the global clear aligner market. Michael breaks down the full investment thesis, including the Invisalign ecosystem, iTero scanner moat and whether the market may be underestimating the durability of Align’s digital orthodontics platform amid rising competition from Straumann, Envista and Angelalign.

During the episode, Michael takes Align through his full quality framework, financial statement analysis, valuation work and technical setup. Topics include Reverse DCF analysis, Forward EV/EBIT valuation, TSR underwriting scenarios, ASP compression and whether Align still deserves a premium multiple long-term.

Finally, Michael explains why he’s adding the stock to his watch list and what business signals and price points he’s looking to see before potentially upgrading it to a buy.

----------------------------------------------------------------

00:00 Intro

00:49 Investment Checklist & Database

02:46 Business Overview

12:13 Industry Overview

17:16 Quality Growth Profile

19:57 Financial Statement Overview

25:17 Leadership & Incentives

29:48 KPIs to Track

31:14 Valuation & Technical Analysis

34:56 Verdict

36:40 Outro

----------------------------------------------------------------

Intro Music: Andrey Rossi – Seize the Day

Outro Music: Ra – Prospect

*Music provided by Uppbeat Premium

Follow me on X: https://x.com/invest091

Listen on YouTube: https://www.youtube.com/@stockspotlightpodcast

Subscribe to the newsletter: https://stockspotlightpodcast.substack.com/

----------------------------------------------------------------

Disclosure: The host of Stock Spotlight is not a licensed financial advisor. The information and opinions shared during the show are for entertainment purposes only.